Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcy E MacDonald

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Science'S STKE : Signal Transduction Knowledge Environment|November 6, 2003
Huntingtin: alive and well and working in middle managementMarcy E MacDonald
BMC Neuroscience|November 25, 2003
An over-expression system for characterizing Ppt1 function in DrosophilaChristopher A Korey, Marcy E MacDonald
Biological Psychiatry|December 7, 2007
Expanding the notion of disease in Huntington's diseaseJames F Gusella, Marcy E MacDonald
Trends in Biochemical Sciences|July 11, 2006
Huntington's disease: seeing the pathogenic process through a genetic lensJames F Gusella, Marcy E MacDonald
Genome Medicine|September 4, 2009
Huntington's disease: the case for genetic modifiersJames F Gusella, Marcy E MacDonald
American Journal of Human Genetics|July 8, 2022
Inherited HTT CAG repeat length does not have a major impact on Huntington disease durationJong-Min Lee, Marcy E MacDonald, James F Gusella
Human Molecular Genetics|June 25, 2021
Huntington's disease: nearly four decades of human molecular geneticsJames F Gusella, Jong-Min Lee, Marcy E MacDonald
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2014
Genetic modifiers of Huntington's diseaseJames F Gusella, Marcy E MacDonald, Jong-Min Lee
BMC Neuroscience|January 15, 2005
Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregationJin Wang, Silvia Gines, Marcy E MacDonald, et al.
Neuromolecular Medicine|October 7, 2003
Huntington's diseaseMarcy E MacDonald, Silvia Gines, James F Gusella, et al.
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Science'S STKE : Signal Transduction Knowledge Environment|November 6, 2003
Huntingtin: alive and well and working in middle managementMarcy E MacDonald
BMC Neuroscience|November 25, 2003
An over-expression system for characterizing Ppt1 function in DrosophilaChristopher A Korey, Marcy E MacDonald
Biological Psychiatry|December 7, 2007
Expanding the notion of disease in Huntington's diseaseJames F Gusella, Marcy E MacDonald
Trends in Biochemical Sciences|July 11, 2006
Huntington's disease: seeing the pathogenic process through a genetic lensJames F Gusella, Marcy E MacDonald
Genome Medicine|September 4, 2009
Huntington's disease: the case for genetic modifiersJames F Gusella, Marcy E MacDonald
American Journal of Human Genetics|July 8, 2022
Inherited HTT CAG repeat length does not have a major impact on Huntington disease durationJong-Min Lee, Marcy E MacDonald, James F Gusella
Human Molecular Genetics|June 25, 2021
Huntington's disease: nearly four decades of human molecular geneticsJames F Gusella, Jong-Min Lee, Marcy E MacDonald
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2014
Genetic modifiers of Huntington's diseaseJames F Gusella, Marcy E MacDonald, Jong-Min Lee
BMC Neuroscience|January 15, 2005
Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregationJin Wang, Silvia Gines, Marcy E MacDonald, et al.
Neuromolecular Medicine|October 7, 2003
Huntington's diseaseMarcy E MacDonald, Silvia Gines, James F Gusella, et al.
Pageof 15